Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

LIST OF FIGURES

Back back Resources Index resources index
Printer-Friendly Version resources index

List of Figures Chapter I: Trends in Organ Donation and Transplantation in the United States, 1999-2008
I-1 Kidney Transplantation at a Glance
I-2 Pancreas Transplantation Alone (PTA) at a Glance
I-3 Pancreas After Kidney (PAK) Transplantation at a Glance
I-4 Simultaneous Pancreas-Kidney (SPK) Transplantation at a Glance
I-5 Liver Transplantation at a Glance
I-6 Intestine Transplantation at a Glance
I-7 Heart Transplantation at a Glance
I-8 Lung Transplantation at a Glance

Chapter II: Organ Donation and Utilization in the United States, 1999-2008
II-1 Total Number of Donors of All Organs Recovered for Transplant, 1999-2008
II-2 Trends in Utilization of Hormonal Resuscitation by Deceased Donor Type
II-3 Utilization of Various Preservation Solutions in Deceased Donor Heart Preservation
II-4 Utilization of Various Preservation Solutions in Deceased Donor Kidney Preservation
II-5 Total Number of Donors of All Organs Recovered for Transplant, 1999-2008
II-6 OPO Conversion Rates in 2008
II-7 Deceased Donors per Million Population in Each Donation Service Area in 2008
II-8 Average OTPD at OPOs in 2008

  Chapter III: Kidney and Pancreas Transplantation in the United States, 1999-2008: The Changing Face of Living Donation
III-1 Number of New and Prevalent Kidney Waiting List Patients and Deaths on the Waiting List, 1999 to 2008
III-2 Waiting List Death Rates by Diagnosis,* 1999 to 2008
III-3 Active/Inactive Status of Kidney Waiting List Candidates at Year-End, 1999-2008
III-4 SCD, ECD, and DCD Kidney Transplants, 1999-2008
III-5 Average Conversion and Discard Rates for All OPOs, 2002-2008
III-6 Unadjusted 1-Year (2006-2007), 5-Year (2002-2007), and 10-Year (1997-2007) Kidney Recipient Survival, by Donor Type
III-7 Unadjusted 1-Year (2006-2007), 5-Year (2002-2007), and 10-Year (1997-2007) Kidney Graft Survival*, by Donor Type
III-8 Unadjusted Median Time to Transplant by OPO (listed from July 1, 2002 - December 31, 2007) for Kidney
III-9 New Registrations on Pancreas Waiting List, by Transplant Type, 1999-2008
III-10 Pancreas Transplants, by Transplant Type, 1999-2008
III-11 Number of Recipients Living with a Functioning Pancreas Transplant at End of Year, 1999-2007
III-12 Unadjusted 1-Year, 3-Year, 5-Year, and 10-Year Pancreas Patient Survival, by Transplant Type
III-13 Unadjusted 1-Year, 3-Year, 5-Year, and 10-Year Pancreas Graft Survival*, by Transplant Type
III-14 Trends in Living Related and Living Unrelated Donors, 1999-2008
III-15 Trends in Living Donor Age, 1999-2008
III-16 Trends in Living Donor Creatinine, 1999-2008
III-17 Trends in Living Donor Retransplantation, 1999-2008
III-18 Percentage of Living Donor Kidney-Alone Transplant by Recipient Age, 1999-2008 Data
III-19 Living Donor Transplants / ESRD Population, 1999-2008
III-20 DSA/ABO Median Wait Time vs. % Living Donor Transplantation, 1999-2008
III-21 Trends in Recipient Steroids, Maintenance, and Induction Therapy, 1999-2008
III-22 Living Donor Recipient Age by Year of Transplant, 1999-2008
III-23 Graft Survival for Pediatric Kidney Transplants by Donor Type Performed in the 2 Years Pre- or Post-Share 35
III-24 Trends in Paired Donation, 2000-2008
III-25 Facility Clustering by ABO Incompatible and PRA 80+ (non-0 mismatch), 1999-2000 vs. 2007-2008
III-26 Trends in Procedure Type, 1999-2008
III-27 Facility Clustering by Procedure Type, 1999-2000 vs. 2007-2008

  Chapter IV: Liver Transplantation in the United States, 1999-2008
IV-1 Number of candidates on the liver waiting list by the end of the calendar year
IV-2 Patients Alive on the Waiting List at Any Time During the Year and Annual Drop Out (removal for death or being too sick) Rates From the Liver Waiting List per 1,000 patient-years
IV-3 Comparison of HCC Liver Recipients to All Liver Recipients by Year of Transplant
IV-4A Number of Deceased Donor Liver Transplants by Age, 1999-2008
IV-4B Number of Deceased Donor Liver Transplants by Recipient Ethnicity/Race, 1999-2008
IV-5A Proportion of HCC Liver Recipients Receiving any Pretransplant Loco-regional Therapy by Year of Transplant
IV-5B Comparison of Different Modalities Utilized for Loco-regional Therapy by Year of Transplant for Treated Liver Recipients
IV-6 Distribution of Time From Listing Until Transplant Liver Recipients by Year of Transplant
IV-7 Proportion of Liver Transplant Recipients with a Waiting Time of 90 days or Less by Region
IV-8A Unadjusted 3-month, 1-year, 5-year and 10-year Graft and Patient Survival - Deceased Donor
IV-8B Unadjusted 3-month, 1-year, 5-year and 10-year Graft and Patient Survival - Living Donor
IV-9A One-Year Adjusted Deceased Donor Graft and Patient Survival by Year of Transplantation
IV-9B One-Year Adjusted Living Donor Graft and Patient Survival by Year of Transplantation
IV-10 Patient Survival in HCV Patients Compared to HCV Negative Patients
IV-11 Donor Risk Index for Primary Liver Transplants from 1999-2008
IV-12 Retransplantation Rate Based on Donor DRI in Primary Liver Transplantation
IV-13 Donor Risk Index for Livers Used for Retransplantation from 1999-2008
IV-14 DCD Utilization and Impact on Retransplantation from 1999-2008
IV-15 Ratio of Primary Liver Transplants to Liver Retransplants by Recipient Age from 1999-2008
IV-16 One-Year Patient Survival Following Primary Liver or First Re-Transplantation by Year
IV-17 Number and Patient Survival Outcome Following Retransplantation by Quartile - 1998-2007
IV-18 One-year Adjusted Patient Survival by Year of Transplantation for Simultaneous Liver-Kidney and Liver only Recipients
IV-19 Unadjusted Patient Survival By HCV Status Among SLK Recipients

  Chapter V: Intestine Transplantation in the United States, 1999-2008
V-1A Number of Candidates on the Intestine Waiting List at Year-End by Age, 1999-2008: Intestine Only
V-1B Number of Candidates on the Intestine Waiting List at Year-End by Age, 1999-2008: Also Listed for Liver
V-2 Adjusted Median Time to Transplant (TT) for New Intestine Waiting List Registrations, 1999-2008
V-3 Unadjusted Death Rates per 1,000 Patient Years at Risk for Patients on the Waiting List by Organ, 1999-2008
V-4A Initial Listings of Candidates for Intestine and Other Organ Transplants on the Same Day, 1999-2008
V-4B Additional Organ Transplant Listings in Candidates Previously Listed for Intestine Transplant, 1999-2008
V-5 Unadjusted Patient and Graft Survival for Isolated Intestine and Intestine with Liver Recipients

  Chapter VI: Heart Transplantation in the United States, 1999-2008
VI-1 2008 Incidence of Heart Transplants per 1 Million Population
VI-2 Status of Heart Transplant Waiting List Candidates, 1999-2008
VI-3 Condition of Status 1A Patients on Heart Waiting list as of January 1, 2008 by Day
VI-4 Condition of Status 1B Patients on Heart Waiting list as of January 1, 2008 by Day
VI-5 Condition of Status 2 Patients on Heart Waiting list as of January 1, 2008 by Day
VI-6 Annual Death Rates per 1,000 Patient-Years on the Heart Waiting List by Status, 2001-2008
VI-7 2008 Annual Death Rates on Heart Waiting List
VI-8 Number of Heart Transplants and Incidence of Transplant per Million Population, 1999-2008
VI-9 Waiting List Status of Heart Transplant Recipients at Transplant, 1999-2008
VI-10 Donor Utilization - Number of Hearts Recovered and Transplanted per 100 Standard-Criteria Donors by Donor Service Area in 2007-2008
VI-11 Posttransplant Patient Survival by Age
VI-12 Adjusted Short- and Long-Term Survival of Heart Recipients, by Year of Transplant, 1995-2007
VI-13 Annual Death Rate per 1000 Patient-Years at Risk for Recipients during First Year after Heart Transplantation, 1999-2007
VI-14 Annual Death Rate per 1000 Patient-Years at Risk during First Year after Heart Transplantation by Status, 1999-2007
VI-15 Annual Death Rates per 1000 Patient-Years during First Year following Heart Transplantation by Race/Ethnicity, 1999-2007
VI-16 Heart Recipients on a VAD at Time of Transplantation by Age and Year, 1999-2006
VI-17 Annual Death Rate for Pediatric Candidates (<18 Years) by Status on the Heart Waiting List
VI-18 2008 Wait-List Mortality by Age
VI-19 Posttransplant Patient Survival by Age
VI-20 Heart Candidates and Heart Recipients with Prior Heart/Heart-Lung Transplant

  Chapter VII: Lung Transplantation in the United States, 1999b2008
VII-1 Number of patients active on the lung transplant waiting list by year (2006-2008) and by diagnosis group (A, B, C, D)
VII-2 Median LAS at listing and at transplant by diagnosis group (A,B,C,D) for patients who received lung transplants between 2006-2008*
VII-3 Median time to transplant by diagnosis group (A,B,C,D) and LAS group at listing for patients who received lung transplants during 2006-2008*
VII-4 Death rate for patients placed on the lung waiting list from 05/04/2005 to 12/31/2007, stratified by primary diagnostic grouping and LAS at time of listing**
VII-5 Number of deceased donor transplants, 1999-2008*
VII-6 Deceased donor lung transplant recipients in intensive care unit (ICU) at time of transplantation, 1999-2008*
VII-7 Primary diagnosis of deceased donor transplant recipients, 1999-2008*
VII-8 Unadjusted patient survival for recipients of deceased donor transplants, by year of transplant, 1999-2007*
VII-9 Unadjusted patient survival for recipients of deceased donor transplants, by primary diagnosis*
VII-10 Unadjusted patient survival for recipients of deceased donor transplants, by recipient age (in years)*
VII-11 Unadjusted patient survival for recipients of deceased donor transplants, by care setting at time of transplantation*
VII-12 One-year posttransplant survival by diagnosis group and LAS group at transplant for patients who received lung transplants from 5/4/05 through 12/31/07**
VII-13 Death Rates for Lung Patients on the Waiting List in 2008 and Lung Transplant Recipients in 2007, Stratified by LAS*
VII-14 Trends in induction immunosuppression for lung transplantation, 1999-2008
VII-15 Trends in maintenance immunosuppression during lung transplantation hospitalization, 1999-2008*
VII-16 Percentage of lung transplant recipients continuing initial maintenance immunosuppression at 1, 2, and 3 years posttransplant, for four most common regimens 2006*
VII-17 Antilymphocyte antibody therapy for rejection episodes in first year following lung transplantation, 1998-2007*
VII-18 Pediatric patients listed for lung transplant, deaths on the waiting list, and transplanted, 1999-2008
VII-19 Ratio of lung waiting list deaths to transplants, pediatric and adult, 1999-2008*

  Chapter VIII: Geographic Variation in End-Stage Renal Disease Incidence and Access to Deceased Donor Kidney Transplantation
VIII-1 Organ Demand Affects Access To Kidney Transplant Independent of Organ Supply, Provider Behaviors, and Patient Characteristics
VIII-2 Growing Incident ESRD, New Kidney Transplant Waiting List, Kidney Transplant, and Donor Populations, 2000-2008
VIII-3 Geographic Variation in ESRD Incidence Rates by DSA
VIII-4 Geographic Variation in Kidney Donation Rates by DSA
VIII-5 Donor Organ Supply and Demand for Kidney Transplantation
VIII-6 Relative Rate** of Primary Kidney Transplant Among New ESRD Patients by the ESRD Incidence Rate and Donation Rate of the Patient's DSA, 2000-2008

  Chapter IX: DonorNet and the Potential Effects on Organ Utilization
IX-1 Mean Ischemic Time for Transplanted Organs, by Organ and Time Period
IX-2 Mean Cold Ischemic Time for Transplanted Kidneys, by Sharing and Time Period
IX-3 Mean Ischemic Time for Transplanted Intestines, by Sharing and Time Period
IX-4 Mean Cold Ischemic Time for Transplanted Livers, by Sharing and Time Period
IX-5 Mean Ischemic Time for Transplanted Pancreas, by Sharing and Time Period

  Chapter X: Access and Outcomes among Minority Transplant Patients, 1999-2008, With a Focus on Determinants of Kidney Graft Survival
X-1 Ratio of Percent of Kidney Transplants and Percent on Active Waiting List at End of Prior Year, 2000-2008
X-2 Adjusted Deceased Donor Kidney Graft Survival by Race/Ethnicity
X-3 Adjusted Deceased Donor Kidney Patient Survival by Race/Ethnicity
X-4 Ratio of Percent of Liver Transplants and Percent on Active Waiting List at End of Prior Year, 2000-2008
X-5 Adjusted Deceased Donor Liver Patient Survival by Race/Ethnicity
X-6 Ratio of Percent of Heart Transplants and Percent on Active Waiting List at End of Prior Year, 2000-2008
X-7 Adjusted Heart Patient Survival by Race/Ethnicity
X-8 Ratio of Percent of Lung Transplants and Percent on Active Waiting List at End of Prior Year, 2000-2008
X-9 Adjusted Deceased Donor Lung Patient Survival by Race/Ethnicity
X-10 Ratio of Percent of SPK Transplants and Percent on Active Waiting List at End of Prior Year, 2000-2008
X-11 Adjusted Deceased Donor SPK Kidney Graft Survival by Race/Ethnicity
X-12 Adjusted Deceased Donor SPK Pancreas Graft Survival by Race/Ethnicity
X-13 Adjusted Deceased Donor SPK Patient Survival by Race/Ethnicity
X-14 Adjusted Deceased Donor Intestine Patient Survival by Race/Ethnicity